Publication | Closed Access

Feasibility study of intraarterial vs intravenous cisplatin, BCNU, and teniposide combined with systemic cisplatin, teniposide, cytosine arabinoside, glycerol and mannitol in the treatment of primary and metastatic brain tumors

Neuro-oncologyMetastatic Brain TumorsSystemic CisplatinOncologyGliomaMedicineAnti-cancer AgentFeasibility StudyCancer TreatmentPharmacologyRadiation Oncology